The U.S. Centers for Medicare & Medicaid Services is requiring drug makers to include “list prices” in television ads for all medicines covered by Medicare or Medicaid that cost $35 or more.
By Erica R. Hendry
The event, staged in a Capitol hearing room, comes amid growing tensions between House Democrats and the White House.
By Christine Vestal, Stateline
The same lethal drug that has been driving the nation’s spiraling opioid epidemic is also causing an historic surge in overdose deaths among cocaine users.
By Summer Ballentine, Associated Press
The bill needs at least one more vote of approval in the GOP-led House before it can go to Republican Gov. Mike Parson, who voiced support for it on Wednesday.
By Karen Matthews, Associated Press
In announcing his candidacy, de Blasio seeks to claim a role on the national stage that has eluded him as mayor of the biggest U.S. city.
By Amanda Morris, Associated Press
The state's attorney general accused Juul's marketing practices of causing an "epidemic" among young people.
By Janie Har, Associated Press
The San Francisco-based utility sparked the Nov. 8 fire in the Pulga area that nearly destroyed Paradise and killed 85 people.
President Trump is returning to a familiar issue: immigration. On Thursday, Trump is expected to deliver a speech in which he proposes an overhaul of the U.S. immigration system, including the number of immigrants accepted, development of a wall between…
With the Supreme Court's conservative makeup, more states are implementing legislation that tests the limits of Roe v. Wade. Alabama's governor has signed the most restrictive abortion law in the country, while Vermont aims to preserve abortion rights into the…
Affordable health care is a persistent concern for Americans and a topic of great political debate. Typically, generic prescription drugs offer a cheaper alternative to name brands, but a new multi-state lawsuit alleges that their manufacturers have been artificially raising…
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.